{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:11:53Z","timestamp":1778703113931,"version":"3.51.4"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jns.2026.125960","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:31:25Z","timestamp":1777332685000},"page":"125960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reconsidering peripheral immune markers in Parkinson's disease: Methodological reflections on recent findings"],"prefix":"10.1016","volume":"486","author":[{"given":"Arif","family":"Sahin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ismah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Ayu","family":"Herawati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muh. Azhar","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia Rizki","family":"Pautina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"September 2025","key":"10.1016\/j.jns.2026.125960_bb0005","article-title":"A cross-sectional exploration of the relationship between Parkinsons disease and peripheral blood immune cells in an ethnically diverse East London population","volume":"484","author":"Kenny","year":"2026","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125960_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-023-03380-7","article-title":"Neutrophil to lymphocyte ratio in Parkinsons disease: a systematic review and meta-analysis","volume":"23","author":"Hosseini","year":"2023","journal-title":"BMC Neurol."},{"issue":"10","key":"10.1016\/j.jns.2026.125960_bb0015","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/mds.28685","article-title":"Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinsons disease","volume":"36","author":"Mu\u00f1oz-Delgado","year":"2021","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2026.125960_bb0020","article-title":"Peripheral inflammatory immune response differs among sporadic and familial Parkinson\u2019s disease","volume":"9","author":"Mu\u00f1oz-Delgado","year":"2023","journal-title":"npj Park. Dis."},{"issue":"19","key":"10.1016\/j.jns.2026.125960_bb0025","first-page":"5543","article-title":"Lymphocyte count and neutrophil-to-lymphocyte ratio are associated with mild cognitive impairment in Parkinsons disease: a single-Center longitudinal study","volume":"11","author":"Contaldi","year":"2022","journal-title":"Stomatology"},{"key":"10.1016\/j.jns.2026.125960_bb0030","article-title":"The diagnostic value of neutrophil to lymphocyte ratio, albumin to fibrinogen ratio, and lymphocyte to monocyte ratio in Parkinsons disease: a retrospective study","volume":"15","author":"Li","year":"2024","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2026.125960_bb0035","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3233\/JPD-212914","article-title":"Peripheral immune cell numbers and C-reactive protein in Parkinsons disease: results from a population-based study","volume":"12","author":"Dommershuijsen","year":"2022","journal-title":"J. Parkinsons Dis."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2600242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2600242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:07:01Z","timestamp":1778702821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X2600242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":7,"alternative-id":["S0022510X2600242X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.125960","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reconsidering peripheral immune markers in Parkinson's disease: Methodological reflections on recent findings","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125960"}}